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Abstract
Disease or pathogen risk prioritisations aid understanding of infectious agent impact within surveillance or mitigation and
biosecurity work, but take significant development. Previous work has shown the H-(Hirsch-)index as an alternative proxy.
We present a weighted risk analysis describing infectious pathogen impact for human health (human pathogens) and well-
being (domestic animal pathogens) using an objective, evidence-based, repeatable approach; the H-index. This study
established the highest H-index European pathogens. Commonalities amongst pathogens not included in previous
surveillance or risk analyses were examined. Differences between host types (humans/animals/zoonotic) in pathogen H-
indices were explored as a One Health impact indicator. Finally, the acceptability of the H-index proxy for animal pathogen
impact was examined by comparison with other measures. 57 pathogens appeared solely in the top 100 highest H-indices
(1) human or (2) animal pathogens list, and 43 occurred in both. Of human pathogens, 66 were zoonotic and 67 were
emerging, compared to 67 and 57 for animals. There were statistically significant differences between H-indices for host
types (humans, animal, zoonotic), and there was limited evidence that H-indices are a reasonable proxy for animal pathogen
impact. This work addresses measures outlined by the European Commission to strengthen climate change resilience and
biosecurity for infectious diseases. The results include a quantitative evaluation of infectious pathogen impact, and suggest
greater impacts of human-only compared to zoonotic pathogens or scientific under-representation of zoonoses. The
outputs separate high and low impact pathogens, and should be combined with other risk assessment methods relying on
expert opinion or qualitative data for priority setting, or could be used to prioritise diseases for which formal risk
assessments are not possible because of data gaps.
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Introduction
Disease or pathogen risk prioritisation exercises are used by
organisations charged with providing surveillance and mitigation
measures including disease management and control, and
biosecurity measures. Qualitative, semi-quantitative or quantita-
tive approaches can be used, but most take significant time to
develop, so their use is limited, and when research involving the
study of multiple diseases or pathogens is planned, agents are
rarely systematically selected.
Quantitative measures for risk prioritisation include the
calculation of epidemiological parameters such as disease inci-
dence, prevalence, mortality and morbidity rates, costs of
prevention, treatment or control, and for human disease, years
lived with disability (YLD) and disability-adjusted-life-year esti-
mates (DALY). Additional measures for animals include losses to
production. For many diseases, robust estimates of these measures
do not exist. Semi-quantitative and qualitative risk assessments are
less demanding of data than quantitative approaches. Neverthe-
less, they require significant time and physical resources (for
example, to obtain parameters and effect sizes from the scientific
literature), need updating regularly, and they usually require
expert-opinion, adding subjectivity [1,2,3,4,5].
The H-index is an alternative approach to disease prioritisation.
It objectively and rapidly provides a quantitative proxy of human
disease or pathogen impact [6],(McIntyre, unpublished). The H-
index captures scientific interest in a disease by deriving a metric
from the number of papers published and how many citations
each receives. Combining scientific impact (citations) with
technical productivity (papers published) is useful as, individually,
total papers does not account for the quality of publications, while
citation count may be influenced by a small number of seminal
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papers or if a disease becomes ‘fashionable’ briefly. The H-index
method is significantly correlated with more comprehensive
measures of human infectious disease impact, including DALYs
[6], and deaths from disease (McIntyre, unpublished data). It can
be rapidly obtained at low cost, attained automatically, and
repeated regularly to reflect changes in impact, serving as a generic
tool to assess the relative bearing of diseases or pathogens, in an
easier, timelier manner than traditional risk assessments. While the
H-index method undoubtedly has limitations, these tend to be
different to those of other approaches; its use could be a step
forward in separating high and low priority diseases or pathogens,
in combination with other risk assessment methods.
The ENHanCEd Infectious Diseases (EID2) database integrates
published data sources on pathogens, their hosts (including vectors)
and geographic ranges [7]. By coupling the H-index method with
the EID2, the primary aim of this study was to establish priority
lists of human and domestic animal pathogens (including zoonoses)
present in Europe. We then consider reasons for the omission of
some pathogens in our lists from those of other disease
prioritisations: the 2010 Global Burden of Disease (GBD) estimates
[8], communicable human diseases reportable in the European
Community [9], the OIE list of notifiable animal diseases,
infections and infestations [10], and the EU FP7 DISCON-
TOOLS project [11]. The GBD 2010 study was a large
collaborative five year project which used all relevant published
and unpublished evidence to create the strongest evidence-based
epidemiological assessment of people’s infectious and non-infec-
tious health problems around the world [8]. The DISCON-
TOOLS project, funded by the European Commission over five
years, investigated the impacts of 52 domestic animal diseases, to
focus and prioritise future research [11]. As the zoonotic and
emerging status of pathogens as well as their taxonomic division
could affect the likelihood of their inclusion in surveillance and
impact quantification work, these factors were also investigated as
reasons for omission from the other disease prioritisations.
The H-index can be obtained in the same way for both human
and animal pathogens. It therefore has potential as a single metric
for prioritising across both host groups. Its potential as a
quantitative One Health indicator (i.e. a single measure applicable
to both human and animal diseases) was investigated by
comparing scores for human-only, zoonotic, and animal-only
pathogen groups, including emerging status as this would likely
drive research impact.
Previous work has shown that the H-index is a proxy for human
disease impact [6],(McIntyre, unpublished). We investigated its
value as a proxy for animal disease impact by comparing domestic
animal pathogen H-indices with other measures of impact
including presence on the OIE list [10], and inclusion in
DISCONTOOLS [11].
Methods
EID2 pathogen information
The EID2 database collates data on human and domestic
animal pathogens: where, when, and in which hosts there is
evidence of their occurrence. The database is built largely using
automated procedures to interrogate publicly available databases.
An EID2 background has been described previously [7]; here, we
used similar criteria to define pathogens, including pathogenic
status (frequently pathogenic: a pathogen which frequently causes
a clinically pathogenic effect - morbidity or mortality - in humans
or domestic animals; non-pathogenic: an organism which causes
no clinical signs within any of its hosts; unknown pathogenicity: an
organism for which there is insufficient evidence to decide),
evidence of pathogens affecting hosts (‘host-pathogen interactions’:
evidence from at least one piece of meta-data uploaded with DNA
or RNA sequence information to [12], which describes where,
when and from which host the pathogen came, or specific
scientific publications [13]), and evidence of pathogens occurring
within countries (evidence from at least one piece of meta-data
[12], or at least five publications in [13] where pathogen name and
a country MeSH-term [14] co-occurred in the title/abstract).
Information on host-pathogen interactions was collated when
there was evidence of a pathogen occurring in at least one host of
interest to the study (including humans and European domestic
animals; see Table 1). Further information about each organism,
such as their taxonomic division for pathogens (bacteria –
including rickettsia, fungi – including algal pathogens, helminths
– including thorny-headed worms and pentastomids, protozoa,
and viruses – including prion agents) or their taxonomic rank
(genus, species, etc.) is stored using a series of statements.
Previously, we examined characteristics of pathogen species [7];
here, we include sub-species, to account for important strains e.g.
Escherichia coli O157:H7.
Emerging/zoonotic pathogen status
Information on whether pathogens were zoonotic, non-zoonot-
ic, emerging and not emerging was examined based upon
previously published information [15,16]. If not included in
earlier work or if their status had changed due to more recent
scientific evidence, updated pathogen information was based upon
the previous definitions. Zoonotic pathogens were classified as
those naturally transmitted between vertebrate (non-human)
animals and humans (as the definitive host), not including species
which have recently evolved from animal pathogens but are no
longer transmitted between animals and humans [15,17]. Emerg-
ing pathogens are those that have appeared in a host population
for the first time (including newly-evolved strains), or have
occurred previously but are increasing in incidence or expanding
into areas where they had not previously been reported [15,17].
Pathogens needed to have emerged in several geographically
distinct areas to be ‘emerging’.
H-index literature search protocol
Information sources. H-index searches were undertaken in
January 2012 using Web of Science (WoS) [18]. Previous work
established that results of H-index searches for pathogens
undertaken using different bibliographic sources (e.g. WoS,
SCOPUS, Google Scholar) are not identical but are highly
correlated [6].
Eligibility criteria. Searches were restricted to the years
1900 to 2010, inclusive. English is used in WoS, however searches
also include foreign-language publication title translations. All
literature in the WoS database has been published.
Searches. Searches were undertaken using search phrases
specified in quotation marks (‘‘’’), the ‘topic’ search field and with
no lemmatization. Phrases were compiled including pathogen
scientific name, alternative names, synonyms and alternative
spellings according to NCBI Taxonomy [19]. H-indices for clinical
diseases used clinical terms as well as pathogen phrases for the
main pathogens of disease. Virus searches also included synonyms
and acronyms from the NCBI Taxonomy database and Interna-
tional Committee on Taxonomy of Viruses [19,20], and the term
‘virus’, and excluded other entities (viral or non-viral) which
shared acronyms. The Boolean operators ‘AND’, ‘OR’, and
‘NOT’ linked multiple search phrases.
Example of a search phrase. (‘‘mycobacterium tuberculo-
sis’’ OR ‘‘bacillus tuberculosis’’ OR ‘‘bacterium tuberculosis’’ OR
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‘‘mycobacterium tuberculosis typus humanus’’ OR ‘‘mycobacte-
rium tuberculosis var. hominis’’).
Pathogen prioritisation framework
A full list of human and domestic animal pathogens frequently
causing pathogenic effects and for which there was evidence of
European occurrence was created using EID2 information [7],
and defined criteria, see Figure 1. The relative impact of
pathogens in this full list was assessed by calculating H-indices
using the specified search protocol; high impact pathogens had the
highest H-indices. The list was split according to host-pathogen
interaction information, into two directories, one including
pathogens with evidence of their occurrence in humans, and the
second including domestic animal occurrence; zoonotic pathogens
appeared in both lists. Information was manually obtained on
whether these pathogens cause diseases featuring in other
prioritisation lists [8,10,11], by examining pathogens listed under
each disease’s details in the NCBI MeSH library [14]; specific lists
of diseases had been provided in other work [9,11]. These
additional pieces of information are included in the results
(Tables 2 and 3). Finally, information on the pathogenic status
of each pathogen, whether they frequently occurred in the relevant
hosts and in Europe was verified by the study authors using
manual literature searches of the scientific literature, for the
pathogens with the highest H-indices.
Data analyses
H-indices and previous prioritisations. Pearson’s Chi-
squared tests with Yates’ continuity correction and Fisher’s Exact
Tests (FET) were used to test for differences in counts of pathogens
included in previous work [9,10,11], according to outcomes
including their taxonomic division, zoonotic and emerging status.
Where appropriate, odds ratios (OR) and 95% confidence
intervals (CI) are presented.
H-indices for One Health. Differences in H-indices for
human-only, zoonotic, and animal-only pathogens were examined
using a two-way Analysis of Variance (ANOVA) with log10-
transformation of the response, including emerging status as an
explanatory covariate. Post-hoc Tukey multiple comparisons of
treatments were undertaken using the HSD.test [21].
H-indices for domestic animal pathogens. -OIE list.
Homogeneity of variances of H-indices for animal-only (and not
zoonotic) pathogens included or not within the OIE list of
notifiable animal diseases was examined using the Fligner-Killeen
(median) test. One-way ANOVA thereafter established differences
in the (log10-transformed) H-indices of pathogens included or not
in the OIE list. –DISCONTOOLS. H-indices and DISCON-
TOOLS scores were compared using Spearman’s Rank correla-
tions. If more than one pathogen had been included within disease
information for the DISCONTOOLS rankings (for Campylobac-
ter, Leishmaniasis, and Salmonellosis), the higher H-index score
was used for analyses.
Table 1. Animal species including humans for which pathogens have been studied, including domestic animals we eat or
companion animals we keep as pets, and exotic animals also used as food sources or as pets.
Scientific name Common name Scientific name Common name
Agapornis personata Masked lovebird Lama glama Lama
Agapornis roseicollis Rosy-faced lovebird Lama pacos Alpaca
Anas platyrhynchos Domestic duck Meleagris gallopavo Turkey
Anser anser Domestic goose Melopsittacus undulatus Budgerigar
Bison bison American bison Meriones unguiculatus Mongolian gerbil
Bison bonasus European bison Mesocricetus auratus Syrian golden hamster
Bos indicus Zebu Mus musculus House mouse
Bos taurus Cow Mustela putorius furo Domestic ferret
Camelus dromedarius Dromedary Numida meleagris Helmeted guineafowl
Canis lupus familiaris Domestic dog Nymphicus hollandicus Cockatiel
Capra hircus Domestic goat Oryctolagus cuniculus Domestic rabbit
Capreolus capreolus Roe deer Ovis aries Sheep
Cavia porcellus Domestic guinea pig Ovis aries musimon Mouflon
Cervus elaphus Red deer Pavo cristatus Blue peafowl
Chinchilla lanigera Chinchilla Phasianus colchicus Ring-necked pheasant
Columba livia Domestic pigeon Rangifer tarandus Reindeer
Cricetus cricetus Common hamster Rattus norvegicus Brown rat
Dama dama Fallow deer Rattus rattus Black rat
Equus asinus Domestic donkey Rhombomys opimus Great Gerbil
Equus caballus Domestic horse Serinus canaria Canary
Felis catus Domestic cat Struthio camelus Ostrich
Gallus gallus Chicken Sus scrofa Wild boar
Homo sapiens Humans Sus scrofa domesticus Domestic pig
Lagopus lagopus scotica Red grouse
doi:10.1371/journal.pone.0103529.t001
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All analyses were undertaken using the statistical software
package R [22], with statistical significance determined by a P-
value of less than 0.05.
Results
Priority lists of human and domestic animal pathogens
present in Europe
Two lists each including the top 100 human (Table 2) and
domestic animal pathogens (Table 3) which cause significant
clinical disease and which therefore need consideration from a
health and well-being perspective were short-listed using the H-
index prioritisation method (for alternative names and synonyms
see [19]). When combined, 114 (72.6%) pathogens appeared solely
in the human or animal list, and 43 (27.4%) were in both lists. Of
the top 100 human pathogens, 66 were classed as zoonotic and 67
were emerging, compared to 67 and 57 for domestic animal
pathogens, respectively.
H-indices and previous prioritisations
Of the top 100 human pathogens identified, 42 were either
included in the GBD [8], or are reportable to the EC [9], or both.
Reasons for failure to include pathogens may be that pathogenic
agents cause rarely diagnosed disease (e.g. Human T-lymphotro-
pic Virus 1, Lymphocytic Choriomeningitis Virus, and Moraxella
catarrhalis), or because disease agents are diverse, e.g. pneumonia
or other lung infections (Aspergillus niger, Chlamydophila pneu-
monia, Cryptococcus neoformans, Klebsiella pneumonia, and
Mycoplasma pneumoniae) and gastro-intestinal (GI) symptoms or
GI-tract infections (Aeromonas hydrophila, Bacillus cereus, Bacte-
roides fragilis, Clostridium species, Vibrio parahaemolyticus, and
Yersinia enterocolitica). The impact of chronic disease or diseases
causing low morbidity may be difficult to quantify or seen as less
important (Bartonella henselae, Borrelia burgdorferi, Human
Enterovirus C, Human Herpesvirus group, Human Papillomavi-
rus, Human Parvovirus b19, Mycobacterium bovis, Mycobacterium
avium, and Mycoplasma genitalium). In addition, some pathogens
may generally be commensals or natural biota (Aggregatibacter
actinomycetemcomitans, Candida species, Enterobacter, Enterococ-
cus, Staphylococcus species, Candida tropicalis, Helicobacter pylori,
and Porphyromonas gingivalis) or species existing in the environ-
ment (Acinetobacter baumannii, Burkholderia cepacia, Candida
glabrata, Entamoeba histolytica, Fusarium oxysporum, Gibberella
moniliformis, Proteus mirabilis, Pseudomonas species, Rhizopus
oryzae, Serratia marcescens, Staphylococcus aureus, and Stenotro-
phomonas maltophilia) causing opportunistic infections in immune-
compromised individuals (including those young, old or pregnant);
their impact upon the general population may not be quantified.
Of the top 100 domestic animal pathogens described, 76 were
either notifiable according to the OIE [10], or included in
DISCONTOOLS [11], or both. Reasons for failure to include
may be similar to for human pathogens (only pathogens not
previously mentioned are cited: multiple disease symptoms or lack
of diagnosis – Ascaris suum, Feline Immunodeficiency Virus,
Feline Leukemia Virus, Gallid Herpesvirus 2, Haemonchus
contortus, and Yersinia pseudotuberculosis; causes of specific
disease being diverse, for respiratory infection - Feline Calicivirus,
and GI symptoms - Campylobacter fetus, Cryptosporidium parvum,
and Listeria monocytogenes,; and existing in the environment and
opportunistic - Pseudomonas aeruginosa). In addition, some
omitted pathogens may be production issues with impact difficult
to quantify (Streptococcus agalactiae causing Mastitis in cattle and
Neospora caninum causing abortion in cattle and dogs) and some
may be issues of pets (Canine Parvovirus, Neospora caninum, and
Parainfluenza Virus 5).
For human pathogens in our list (Table 2), fungi and helminths
are particularly under-represented in GBD assessments (percent-
age included in GBD: bacteria, 25%; fungi, 0%; helminths, 0%;
protozoa, 60%; viruses, 42.3%; FET, P=0?046). There was no
difference between taxonomic divisions in the percentage report-
able to the EC (FET, P=0.109). Human pathogens classed as
emerging (compared to not emerging) were statistically more likely
to have GBD estimates (FET, P,0.001, OR=10.27, CI = 2.28–
95.77) and be EC reportable (FET, P,0.001, OR=16.00,
CI = 3.49–144.92), but not more likely to have GBD estimates
or be EC reportable if they were zoonotic compared to non-
zoonotic (Pearson’s x2, P=0.219 and FET, P=0.745, respective-
ly).
For domestic animal pathogens in our list (Table 3), fungi were
particularly under-represented in the OIE list (percentage included
in OIE: bacteria, 20%; fungi, 0%; helminths, 33.3%, protozoa,
33.3%, viruses, 52.5%; FET, P=0.014). By contrast, viruses are
particularly under-represented in DISCONTOOLS (percentage
included in DISCONTOOLS: bacteria, 55.6%; fungi, 100%;
helminths, 33.3%; protozoa, 33.3%; viruses, 25%; FET,
P=0.008). Animal pathogens classed as zoonotic (compared to
non-zoonotic) were (of borderline statistical significance) less likely
to be included in the OIE list (Pearson’s x2, P=0.055, effect
size(ø) = 0.22, OR=0.39) but there was no difference in the
percentage included in DISCONTOOLS, (Pearson’s x2,
P=0.309) nor any effect of being emerging (versus not emerging)
Figure 1. Pyramid diagram showing the prioritisation framework for pathogens leading to the use of the quantitative H-index
methodology to estimate relative pathogen impact.
doi:10.1371/journal.pone.0103529.g001
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Table 2. Top 100 human pathogens in Europe, prioritised according to the H-index methodology [6].
Pathogen name
H-index
score
Taxonomic
division Pathogen name
H-index
score
Taxonomic
division
Escherichia coli, Z, E, A, GBD 524 Bacteria Streptococcus pyogenes, Z, E 113 Bacteria
Human Immunodeficiency Virus 1, NZ, E, GBD, EC 410 Viruses Bacillus cereus, Z, NE, A 111 Bacteria
Human Immunodeficiency Virus 2, NZ, E, GBD, EC 399 Viruses Aspergillus niger, Z, NE 110 Fungi
Hepatitis C Virus, NZ, E, GBD, EC 289 Viruses Burkholderia cepacia, NZ, NE 107 Bacteria
Staphylococcus aureus, Z, E, A 271 Bacteria Clostridium botulinum, Z, E, A, EC 106 Bacteria
Human Herpesvirus 4, NZ, NE 257 Viruses Encephalomyocarditis Virus, Z, NE, A 105 Viruses
Helicobacter pylori, Z, NE, A 246 Bacteria Yersinia pestis, Z, E, A, EC 105 Bacteria
Hepatitis B Virus, NZ, E, GBD, EC 246 Viruses Streptococcus mutans, NZ, NE 104 Bacteria
Pseudomonas aeruginosa, Z, E, A 243 Bacteria Aggregatibacter actinomycetemcomitans, Z, NE 101 Bacteria
Mycobacterium tuberculosis, Z, E, GBD, EC 238 Bacteria Clostridium perfringens, Z, NE, A 101 Bacteria
Human Papillomavirus, NZ, E 235 Viruses Serratia marcescens, Z, E 100 Bacteria
Bacillus subtilis, Z, NE 219 Bacteria Yersinia pseudotuberculosis, Z, NE, A, EC 99 Bacteria
Listeria monocytogenes, Z, E, A, EC 207 Bacteria Entamoeba histolytica, Z, NE, A 98 Protozoa
Streptococcus pneumoniae, Z, E, GBD, EC 199 Bacteria Leishmania donovani, Z, E, A, GBD 98 Protozoa
Candida albicans, Z, E, A 181 Fungi Bacteroides fragilis, Z, NE, A 97 Bacteria
Human Herpesvirus 1, NZ, E 171 Viruses Gibberella moniliformis, NZ, E 97 Fungi
Respiratory Syncytial Virus, NZ, NE, GBD 164 Viruses West Nile Virus, Z, E, A, EC 97 Viruses
Human Herpesvirus 5, NZ, E 159 Viruses Human Herpesvirus 2, NZ, E 96 Viruses
Haemophilus influenzae, NZ, E, GBD, EC 148 Bacteria Rabies Virus, Z, E, A, GBD, EC 96 Viruses
Lymphocytic Choriomeningitis Virus, Z, NE, A 148 Viruses Hepatitis A Virus, Z, E, GBD, EC 95 Viruses
Toxoplasma gondii, Z, E, A, EC 148 Protozoa Human Herpesvirus 6, NZ, NE 94 Viruses
Klebsiella pneumoniae, Z, E, A 146 Bacteria Fusarium oxysporum, NZ, E 93 Fungi
Vibrio cholerae, NZ, E, GBD, EC 145 Bacteria Mycoplasma pneumoniae, NZ, NE 93 Bacteria
Borrelia burgdorferi, Z, E, A 144 Bacteria Cryptosporidium parvum, Z, E, A, GBD, EC 92 Protozoa
Chlamydophila pneumoniae, Z, NE, A 143 Bacteria Enterobacter cloacae, Z, NE, A 90 Bacteria
Shigella flexneri, Z, NE, GBD, EC 142 Bacteria Aeromonas hydrophila, Z, E, A 89 Bacteria
Human Herpesvirus 8, NZ, E 140 Viruses Acinetobacter baumannii, NZ, NE, A 88 Bacteria
Escherichia coli o157:h7, Z, E, EC 138 Bacteria Candida glabrata, Z, E 87 Fungi
Human T-lymphotropic Virus 1, NZ, E 137 Viruses Moraxella catarrhalis, NZ, NE 87 Bacteria
Neisseria gonorrhoeae, NZ, E, GBD, EC 136 Bacteria Salmonella enterica subsp. enterica serovar
enteritidis, Z, E, A, GBD, EC
87 Bacteria
Influenza A Virus, Z, E, A, GBD, EC 135 Viruses Treponema pallidum, NZ, E, GBD, EC 87 Bacteria
Legionella pneumophila, NZ, E, EC 133 Bacteria Trichomonas vaginalis, NZ, E, GBD 87 Protozoa
Enterococcus faecalis, Z, E 132 Bacteria Rhizopus oryzae, Z, NE 86 Fungi
Mycobacterium bovis, Z, E, A 132 Bacteria Hepatitis E Virus, Z, E, GBD 83 Viruses
Campylobacter jejuni, Z, E, A, GBD, EC 130 Bacteria Human Parvovirus b19, NZ, E 81 Viruses
Neisseria meningitidis, NZ, E, GBD, EC 130 Bacteria Proteus mirabilis, Z, NE, A 80 Bacteria
Chlamydia trachomatis, Z, E, GBD, EC 129 Bacteria Shigella dysenteriae, Z, E, GBD, EC 80 Bacteria
Clostridium difficile, Z, E, A 127 Bacteria Stenotrophomonas maltophilia, NZ, NE 80 Bacteria
Cryptococcus neoformans, Z, E, A 126 Fungi Bacillus licheniformis, Z, NE, A 78 Bacteria
Yersinia enterocolitica, Z, E, A 126 Bacteria Mycoplasma genitalium, NZ, NE 78 Bacteria
Mouse Mammary Tumor Virus, Z, E, NS 125 Viruses Trichinella spiralis, Z, E, A, EC 78 Helminths
Mycobacterium avium, Z, E 125 Bacteria Bartonella henselae, Z, NE, A 77 Bacteria
Bacillus anthracis, Z, E, A, EC 122 Bacteria Salmonella enterica subsp. enterica serovar
typhimurium, Z, E, A, GBD, EC
77 Bacteria
Bordetella pertussis, NZ, E, GBD, EC 122 Bacteria Brucella abortus, Z, E, A, EC 76 Bacteria
Measles Virus, Z, E, GBD, EC 119 Viruses Candida tropicalis, Z, NE 76 Fungi
Human Enterovirus C, NZ, NE 118 Viruses Pseudomonas stutzeri, NZ, NE 76 Bacteria
Enterococcus faecium, Z, E 116 Bacteria SARS coronavirus, Z, E, NS, EC 76 Viruses
Staphylococcus epidermidis, Z, E, A 114 Bacteria Enterobacter aerogenes, Z, NE, A 75 Bacteria
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on inclusion in either list (Pearson’s x2, P=0.633 and P,0.99,
respectively).
H-indices for One Health
There was a statistically significant difference between the H-
indices of zoonotic, human-only or animal-only pathogens (Two-
way ANOVA, F2,152 = 24?40, P,0.001); H-indices were signifi-
cantly higher for human-only (untransformed
mean= 132.3966.14 and lower for animal-only pathogens
(68.1166.06) compared to zoonotic (100.8369.93). H-indices
were higher (with borderline statistical significance) for emerging
(106.61610.19) compared to not emerging (86.9168.14) patho-
gens (Two-way ANOVA, F1,152 = 3.78, P=0.054). The interac-
tion between zoonotic and emerging factors was not significant
(P=0.25).
H-indices for domestic animal pathogens
-OIE list. There was no difference in the H-indices of animal-
only pathogens included or not within the OIE list (ANOVA F(1,
31) = 0?005, MSE,0.001, P=0.943; variances not significantly
different by Fligner-Killeen (median) test.
-DISCONTOOLS. There were significant correlations be-
tween H-indices and DISCONTOOLS estimates of public
(human) health (zoonotic and animal pathogens) and impact on
wider society (animal-only pathogens), and a further relationship
of borderline significance between H-indices and the DISCON-
TOOLS overall result; no other correlations were significant
(Table 4).
Discussion
The European Commission has outlined measures to strengthen
coordinated approaches to health security at EU level, including
monitoring, early warning and combating specific threats of a
cross-border nature. These measures could be for climate change
resilience [23] or for biosecurity, particularly for infectious diseases
including communicable diseases, antimicrobial resistant and
healthcare-associated infections related to communicable diseases,
and biotoxins or other biological agents [24]. In this study, we
implement a number of previously defined actions [25], including
presenting a quantitative evaluation for the impact of infectious
pathogens affecting human health and well-being (via effects upon
domestic animals) [24]. The work is unique, starting with all
known infectious pathogens, and then objectively and systemat-
ically deciding which occur in relevant hosts in Europe using a
transparent process. The study establishes priority lists of human
and domestic animal pathogens (including zoonoses) present in
Europe, using the H-index as a proxy measure for impact.
Previous work suggests that higher H-indices indicate higher
impact for a pathogen relative to lower H-indices [6], (McIntyre,
unpublished material). The H-index method has both strengths
and weaknesses. The strengths include that it is much more
evidence-based and objective than semi-quantitative and qualita-
tive approaches, and the results provide an easily understood
quantitative estimate of impact. H-indices estimates can be simply
and rapidly calculated, and they can therefore be repeatedly
obtained to reflect changes in status, with the potential for
automation of this process. The results are available for all
pathogens at a global scale, and the scores reflect the wider
scientific interest that would be expected to follow from a pathogen
being either zoonotic or emerging [6]. Most importantly, within a
study of 27 human diseases, H-indices were correlated with DALY
estimates [6], (McIntyre, unpublished material). DALYs are an
accepted measure of true disease burden in humans which
accounts for the years of healthy life lost as a result of poor health
or disability as well as the potential years of life lost due to
premature death [26]. In further work, H-indices were also
correlated with the number of human deaths (McIntyre, unpub-
lished material).
The weaknesses of the H-index method include that calculations
need some manual oversight, as false positives can occur for
instance when pathogens are used as model organisms; biases in
results may happen because of trends in interest in specific
pathogens, diseases or research fields or in certain regions; and
estimates are subject to biases in funding (McIntyre, unpublished
material) and research publication. H-indices are likely to
underestimate the contribution of scientific literature published
in non-English languages, although after translation some
publications are included in WoS and consequently in our
calculations of H-indices. The literature searching method also
doesn’t account for the quality of publications in which pathogen
names appear and the typical number of citations within different
fields, and all bibliographic software packages incorporate newly
published literature from different literature sources into their
databases at different rates. Finally, H-indices are only a proxy for
impact, with the results susceptible to a lag in time-to-publication,
and newly emerging pathogens likely to be under-represented.
As the strengths and weaknesses of using the H-index method
are different to those of other prioritisation methods, it is probably
best used in combination with other approaches, for example, to
shortlist a set of pathogens for more detailed risk assessment
relying on expert opinion or qualitative data. It may also be used
to prioritise diseases for which formal risk assessments are not
possible because of data gaps.
Our priority lists of pathogens enabled investigation of why
infectious pathogens are omitted from disease surveillance and
impact quantification work [8,9,10,11]. We considered several
reasons for exclusion, including lack of diagnosis or misdiagnosis
[27], because the impact of particularly chronic infections is
difficult to quantify or they are seen as less important, and because
some pathogens are commensals or natural biota causing
opportunistic infections in immune-compromised individuals; their
Table 2. Cont.
Pathogen name
H-index
score
Taxonomic
division Pathogen name
H-index
score
Taxonomic
division
Human Herpesvirus 3, NZ, E, GBD 113 Viruses Francisella tularensis, Z, E, A, EC 74 Bacteria
Porphyromonas gingivalis, Z, NE 113 Bacteria Vibrio parahaemolyticus, Z, E 74 Bacteria
Pathogens include those which are zoonotic (Z), non-zoonotic (NZ), emerging (E) and not emerging (NE) [15,16], or given a new status (NS) in this work. Pathogens also
included in the list of top 100 animal pathogens are noted (A). The major pathogens causing diseases included within the 2012 Global Burden of Disease (GBD) report
are noted [8,31], as are those reportable in the EC (EC) [9].
doi:10.1371/journal.pone.0103529.t002
Prioritisation of European Human and Domestic Animal Pathogens
PLOS ONE | www.plosone.org 6 August 2014 | Volume 9 | Issue 8 | e103529
Table 3. Top 100 domestic animal pathogens in Europe, prioritised according to the H-index methodology [6] with the same
emerging and zoonotic definitions as for Table 2.
Pathogen name
H-index
score
Taxonomic
division Pathogen name
H-index
score
Taxonomic
division
Escherichia coli, Z, E, H, DISC 524 Bacteria Salmonella enterica subsp. enterica serovar
typhimurium, Z, E, H, DISC
77 Bacteria
Staphylococcus aureus, Z, E, H 271 Bacteria Brucella abortus, Z, E, H, OIE 76 Bacteria
Helicobacter pylori, Z, NE, H, DISC 246 Bacteria Enterobacter aerogenes, Z, NE, H, DISC 75 Bacteria
Pseudomonas aeruginosa, Z, E, H 243 Bacteria Francisella tularensis, Z, E, H, OIE 74 Bacteria
Listeria monocytogenes, Z, E, H 207 Bacteria Haemonchus contortus, NZ, NE, NS 74 Helminths
Murine Leukemia Virus, Z, E, NS 184 Viruses Neospora caninum, NZ, NE, NS 72 Protozoa
Candida albicans, Z, E, H, DISC 181 Fungi Cowpox Virus, Z, E, NS 71 Viruses
Lymphocytic Choriomeningitis Virus, Z, NE, H 148 Viruses Bovine Herpesvirus 1, NZ, NE, NS, OIE 70 Viruses
Toxoplasma gondii, Z, E, H, DISC 148 Protozoa Citrobacter freundii, NZ, E, NS, DISC 70 Bacteria
Klebsiella pneumoniae, Z, E, H, DISC 146 Bacteria Feline Leukemia Virus, NZ, NE, NS 69 Viruses
Borrelia burgdorferi, Z, E, H, DISC 144 Bacteria Fasciola hepatica, Z, E, NS, DISC 68 Helminths
Chlamydophila pneumoniae, Z, NE, H, DISC 143 Bacteria Reticuloendotheliosis Virus, NZ, NE, NS, DISC 68 Viruses
Influenza A Virus, Z, E, H, OIE 135 Viruses Coxiella burnetii, Z, E, NS, OIE 67 Bacteria
Mycobacterium bovis, Z, E, H, OIE 132 Bacteria Mannheimia haemolytica, Z, NE, NS, DISC 67 Bacteria
Campylobacter jejuni, Z, E, H, DISC 130 Bacteria Infectious Bronchitis Virus, NZ, NE, NS, OIE 66 Viruses
Clostridium difficile, Z, E, H 127 Bacteria Klebsiella oxytoca, NZ, NE, NS, DISC 66 Bacteria
Cryptococcus neoformans, Z, E, H, DISC 126 Fungi Ascaris suum, Z, NE, NS 65 Helminths
Yersinia enterocolitica, Z, E, H 126 Bacteria Borna Disease Virus, Z, E, NS, DISC 65 Viruses
Bacillus anthracis, Z, E, H, OIE 122 Bacteria Bovine Leukemia Virus, NZ, NE, NS, DISC 65 Viruses
Staphylococcus epidermidis, Z, E, H, DISC 114 Bacteria Campylobacter coli, Z, NE, NS, DISC 65 Bacteria
Bacillus cereus, Z, NE, H, DISC 111 Bacteria Canine Parvovirus, NZ, NE, NS 65 Viruses
Clostridium botulinum, Z, E, H, DISC 106 Bacteria Parainfluenza Virus 5, Z, NE, NS 65 Viruses
Suid Herpesvirus 1, NZ, NE, NS, OIE 106 Viruses Pasteurella multocida, Z, NE, NS, OIE 65 Bacteria
Encephalomyocarditis Virus, Z, NE, H, DISC 105 Viruses Porcine circovirus, NZ, E, NS, DISC 65 Viruses
Yersinia pestis, Z, E, H, DISC 105 Bacteria Porcine Reproductive and Respiratory
Syndrome Virus, NZ, E, NS, OIE
65 Viruses
Bovine Spongiform Encephalopathy agent,
Z, E, NS, OIE
101 Viruses Bluetongue Virus, NZ, E,NS, OIE 64 Viruses
Clostridium perfringens, Z, NE, H 101 Bacteria Chlamydophila abortus, Z, E, NS, DISC 63 Bacteria
Yersinia pseudotuberculosis, Z, NE, H 99 Bacteria Chlamydophila psittaci, Z, E, OIE, NS 63 Bacteria
Entamoeba histolytica, Z, NE, H, DISC 98 Protozoa Enterococcus hirae, Z, NE, NS, DISC 63 Bacteria
Leishmania donovani, Z, E, H, OIE 98 Protozoa Gallid Herpesvirus 2, NZ, NE, NS 63 Viruses
Bacteroides fragilis, Z, NE, H, DISC 97 Bacteria Anaplasma phagocytophilum, Z, E, NS, OIE 62 Bacteria
West Nile Virus, Z, E, H, OIE 97 Viruses Equine Infectious Anemia Virus, NZ, NE, NS, OIE 62 Viruses
Rabies Virus, Z, E, H, OIE 96 Viruses Streptococcus agalactiae, Z, E, NS 62 Bacteria
Bovine Papillomavirus, NZ, E, NS, DISC 95 Viruses Echinococcus granulosus, Z, E, NS, OIE 61 Helminths
Newcastle Disease Virus, Z, NE, NS, OIE 93 Viruses Equine Arteritis Virus, NZ, E, NS, OIE 61 Viruses
Cryptosporidium parvum, Z, E, H 92 Protozoa Maedi Visna Virus, NZ, NE, NS, OIE 61 Viruses
Enterobacter cloacae, Z, NE, H 90 Bacteria Canine Distemper Virus, NZ, E, NS, DISC 60 Viruses
Aeromonas hydrophila, Z, E, H, DISC 89 Bacteria Chicken Anemia Virus, NZ, E,NS, DISC 60 Viruses
Foot and Mouth Disease Virus, Z, NE, OIE 89 Viruses Equid Herpesvirus 1, NZ, E, NS, OIE 60 Viruses
Acinetobacter baumannii, NZ, NE, H, DISC 88 Bacteria Infectious Bursal Disease Virus, NZ, NE, NS, OIE 60 Viruses
Salmonella enterica subsp. enterica serovar
enteritidis, Z, E, H, DISC
87 Bacteria Transmissible Gastroenteritis Virus,
NZ, NE, NS, OIE
60 Viruses
Classical Swine Fever Virus, NZ, NE, NS, OIE 84 Viruses Actinobacillus pleuropneumoniae, NZ, E, NS, DISC 59 Bacteria
Bovine Viral Diarrhea Virus 1, NZ, E, NS, OIE 80 Viruses Feline Calicivirus, Z, E, NS 59 Viruses
Feline Immunodeficiency Virus, NZ, E, NS 80 Viruses Myxoma Virus, NZ, NE, NS, OIE 59 Viruses
Proteus mirabilis, Z, NE, H, DISC 80 Bacteria Encephalitozoon cuniculi, Z, E, NS, DISC 58 Fungi
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impact upon the general population may therefore not be
quantified. Recently discovered pathogens may be under-repre-
sented as a sufficient body of evidence for their impact may not
have been accrued within the literature, for example Norovirus
infection does not appear within the top 100 human pathogens. In
addition, domestic pet pathogens, particularly if non-zoonotic or
easily controlled, may not be included. Further analysis suggests
that pathogens fail to be included dependent upon their taxonomic
division (perhaps due to diagnostic issues) and for human
pathogens, if they are not emerging, perhaps as a result of the
‘Matthew effect’ (‘the rich get richer and the poor get poorer’);
equally, they may simply have less long-term impact. The effect of
emerging status is unsurprising, given this focus in surveillance
work and despite a lag in time-to-publication leading to their likely
under-representation in H-index calculations [6]; for some animal
pathogens, this is the first time that emerging status has been
examined.
Methods to assess disease impacts use metrics capturing either
human or animal host effects; they neither measure the magnitude
in all hosts nor take account of scientific knowledge and tools for
control. It is hard to prioritise human and animal diseases, because
of the different metrics used (health or societal impacts versus
welfare or economic impacts). Significant differences between H-
indices mean values for human-only, zoonotic, and animal-only
pathogens provide evidence that this single measure may have
some use as a One Health metric accounting for such factors. For
example values for zoonotic pathogens were higher than for
animal-only, suggesting that they account for human as well as
animal-impact. Higher values for human-only compared to other
pathogen groups suggests that zoonoses may be under-represented
due to underestimation of their global burden [28,29], or research
impact [6], or because of biases in research impact and funding for
chronic human pathogens [29]. In addition, lower animal-only H-
indices may be due to funding biases.
Finally, there was limited evidence that the H-index method is a
reasonable proxy for the impact of animal pathogens; animal
pathogen H-indices were significantly positively correlated with
subsections of DISCONTOOLS [11], including impact on public
(human) health and overall results (borderline significance). If
animal-only (not zoonotic) diseases were included, there was a
significant positive relationship with impact on wider society. As
the more animal-focussed subsections (disease knowledge, impact
on animal health and welfare, impact on trade, and available
control tools) were not correlated with H-indices, and H-indices
were not affected by inclusion in the OIE list [10], this suggests a
human-centric bias in H-indices; for example, a pathogen causing
little impact in animals may nevertheless have a high H-index if
zoonotic.
The priority lists presented in this work should be used by
agencies and research organisations in combination with other risk
assessment methods to identify gaps in working for priority setting.
It has been suggested that zoonoses must be dealt with at the
interface of human and animal health using all available
information [30]; this work, combining the EID2 and H-index
technique, demonstrates such ‘big-data’ approaches.
Table 3. Cont.
Pathogen name
H-index
score
Taxonomic
division Pathogen name
H-index
score
Taxonomic
division
Mycobacterium avium subsp. paratuberculosis,
NZ, E, NS, OIE
79 Bacteria Rotavirus A, Z, E, NS, DISC 58 Viruses
Scrapie agent, NZ, NE, NS, OIE 79 Viruses Campylobacter fetus, Z, E, NS 57 Bacteria
Bacillus licheniformis, Z, NE, H 78 Bacteria Fowlpox Virus, NZ, NE, NS, DISC 57 Viruses
Trichinella spiralis, Z, E, H, OIE 78 Helminths Leishmania infantum, Z, E, NS, OIE 57 Protozoa
Bartonella henselae, Z, NE, H, DISC 77 Bacteria Trichostrongylus colubriformis, Z, NE, NS, DISC 57 Helminths
Pathogens also included in the list of top 100 human pathogens are noted (H). The major pathogens causing diseases included within the OIE list of notifiable terrestrial
and aquatic animal diseases (OIE) are noted [10], as are those included in the DISCONTOOLS project (DISC) [11].
doi:10.1371/journal.pone.0103529.t003
Table 4. Results of Spearman’s Rank correlations between H-indices and the DISCONTOOLS prioritisation of major animal diseases
[11].
Zoonotic and animal-only pathogens Animal-only pathogens
Subsection of prioritisation S rho P value S rho P value
Disease knowledge 0?004 0?987 20?180 0?699
Impact on animal health and welfare 20?048 0?830 0?309 0?500
Impact on public (human) health 0?449 0?032 0?586 0?166
Impact on wider society 0?081 0?713 20?775 0?041
Impact on trade 0?200 0?360 20?216 0?641
Control tools 0?170 0?438 0?093 0?842
Overall results 0?379 0?074* .0?001 ,0?999
Notations include Spearman’s Rank correlation value (S rho) and P values for the correlation. P values of significance are shown in bold, and a relationship of borderline
significance is marked *.
doi:10.1371/journal.pone.0103529.t004
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